RA patients on upadacitinib and methotrexate showed robust antibody and T-cell responses to the recombinant zoster vaccine over 60 weeks. The vaccine maintained a satisfactory humoral response in 71.4 ...
In a recent study published in the journal Allergy, a team of researchers in Austria conducted a longitudinal analysis among individuals who had not been vaccinated against coronavirus disease 2019 ...